Cargando…

Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers

INTRODUCTION: In the search for novel cancer biomarkers, various proteolytically derived peptides have been proposed to exhibit cancer or cancer-type specificity. As these peptides are presumably also generated after sample collection by tumor-specific proteases, extensive investigation of the invol...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Broek, Irene, Sparidans, Rolf W., Schellens, Jan H. M., Beijnen, Jos H.
Formato:	Texto
Lenguaje:	English
Publicado:	Humana Press Inc 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970821/ https://www.ncbi.nlm.nih.gov/pubmed/21124649 http://dx.doi.org/10.1007/s12014-010-9054-z

Ejemplares similares

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies
por: Deenen, Maarten J., et al.
Publicado: (2011)

ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availability
por: Li, Wenlong, et al.
Publicado: (2021)

Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography–tandem mass spectrometry
por: Susam, M. Merve, et al.
Publicado: (2022)

Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran
por: Harnkit, Nathaphat, et al.
Publicado: (2022)

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Urinary peptidomics reveals proteases involved in idiopathic membranous nephropathy
por: Lin, Baoxu, et al.
Publicado: (2021)

P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO)
por: Wang, Yaogeng, et al.
Publicado: (2021)

Salivary peptidome analysis and protease prediction during orthodontic treatment with fixed appliances
por: Wazwaz, Fidaa, et al.
Publicado: (2023)

P-Glycoprotein (MDR1/ABCB1) Restricts Brain Accumulation of the Novel EGFR Inhibitor EAI045 and Oral Elacridar Coadministration Enhances Its Brain Accumulation and Oral Exposure
por: Wang, Jing, et al.
Publicado: (2022)

Optimization for peptide sample preparation for urine peptidomics
por: Sigdel, Tara K, et al.
Publicado: (2014)

Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses
por: Keizer, Ron J, et al.
Publicado: (2015)

Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome
por: Prasertsuk, Kansate, et al.
Publicado: (2022)

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours
por: Siegel-Lakhai, W S, et al.
Publicado: (2005)

The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins
por: Loos, Nancy H.C., et al.
Publicado: (2023)

Defective Proinsulin Handling Modulates the MHC I Bound Peptidome and Activates the Inflammasome in β-Cells
por: Khilji, Muhammad Saad, et al.
Publicado: (2022)

Analysis of the Yeast Peptidome and Comparison with the Human Peptidome
por: Dasgupta, Sayani, et al.
Publicado: (2016)

Mining the Biomarker Potential of the Urine Peptidome: From Amino Acids Properties to Proteases
por: Trindade, Fábio, et al.
Publicado: (2021)

Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Organoid Sample Preparation and Extraction for LC-MS Peptidomics
por: Miedzybrodzka, Emily L., et al.
Publicado: (2020)

Protein versus DNA as a marker for peripheral blood mononuclear cell counting
por: Jansen, Robert S., et al.
Publicado: (2009)

Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients
por: van Andel, L., et al.
Publicado: (2017)

The plasma peptidome
por: Dufresne, Jaimie, et al.
Publicado: (2018)

Peptidomics-Driven Strategy Reveals Peptides and Predicted Proteases Associated With Oral Cancer Prognosis
por: Neves, Leandro Xavier, et al.
Publicado: (2020)

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients
por: van Andel, L., et al.
Publicado: (2017)

Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment
por: van Andel, Lotte, et al.
Publicado: (2018)

Comparative evaluation of peptidome and microbiota in different types of saliva samples
por: Zhu, Ce, et al.
Publicado: (2020)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Peptidome: Chaos or Inevitability
por: Lyapina, Irina, et al.
Publicado: (2021)

Peptidomics of Haemonchus contortus
por: Buzy, Armelle, et al.
Publicado: (2021)

Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling
por: Gast, Marie-Christine W, et al.
Publicado: (2008)

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
por: Kip, Anke E., et al.
Publicado: (2017)

Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites
por: Jager, Nynke GL, et al.
Publicado: (2013)

Treatment Individualization in Colorectal Cancer
por: van Geel, Robin M. J. M., et al.
Publicado: (2015)

An Improved Method for Measuring Absolute Metabolite Concentrations in Small Biofluid or Tissue Samples
por: Fernando, Tharindu, et al.
Publicado: (2019)

Application of Proteomics and Peptidomics to COPD
por: Pelaia, Girolamo, et al.
Publicado: (2014)

Moving the Cellular Peptidome by Transporters
por: Abele, Rupert, et al.
Publicado: (2018)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
por: Keizer, Ron J., et al.
Publicado: (2011)

Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar()
por: Sawicki, Emilia, et al.
Publicado: (2016)

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
por: Verheijen, Remy B., et al.
Publicado: (2017)

Evaluation of Sample Handling Effects on Serum Vitamin E and Cholesterol Concentrations in Alpacas
por: Lear, Andrea S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_09f96qipgji4ob0p639oamcc3e